PlainRecalls
FDA Drug Moderate Class II Terminated

Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC 68462-192-55), Rx Only, Manufactured by; Glenmark Pharmaceuticals Ltd At: Village: Kishanpura, Baddi Nalagari Road, District: Solan, Himachal Pradesh -173205, India Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Reported: August 14, 2019 Initiated: July 23, 2019 #D-1586-2019

Product Description

Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC 68462-192-55), Rx Only, Manufactured by; Glenmark Pharmaceuticals Ltd At: Village: Kishanpura, Baddi Nalagari Road, District: Solan, Himachal Pradesh -173205, India Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

Reason for Recall

GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.

Details

Units Affected
N/A
Distribution
Nationwide within the United States
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC 68462-192-55), Rx Only, Manufactured by; Glenmark Pharmaceuticals Ltd At: Village: Kishanpura, Baddi Nalagari Road, District: Solan, Himachal Pradesh -173205, India Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: N/A.
Why was this product recalled?
GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2019. Severity: Moderate. Recall number: D-1586-2019.